nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—CYP3A4—Esomeprazole—Barrett's esophagus	0.184	0.286	CbGbCtD
Mifepristone—ABCB1—Omeprazole—Barrett's esophagus	0.181	0.281	CbGbCtD
Mifepristone—CYP2D6—Omeprazole—Barrett's esophagus	0.171	0.265	CbGbCtD
Mifepristone—CYP3A4—Omeprazole—Barrett's esophagus	0.109	0.168	CbGbCtD
Mifepristone—Gastrooesophageal reflux disease—Omeprazole—Barrett's esophagus	0.00594	0.0212	CcSEcCtD
Mifepristone—Gastrooesophageal reflux disease—Esomeprazole—Barrett's esophagus	0.00594	0.0212	CcSEcCtD
Mifepristone—NR3C1—FOXA2 and FOXA3 transcription factor networks—FOXF1—Barrett's esophagus	0.00567	0.0754	CbGpPWpGaD
Mifepristone—Rash maculo-papular—Omeprazole—Barrett's esophagus	0.00488	0.0174	CcSEcCtD
Mifepristone—Rash maculo-papular—Esomeprazole—Barrett's esophagus	0.00488	0.0174	CcSEcCtD
Mifepristone—Hot flush—Esomeprazole—Barrett's esophagus	0.00416	0.0149	CcSEcCtD
Mifepristone—Hot flush—Omeprazole—Barrett's esophagus	0.00416	0.0149	CcSEcCtD
Mifepristone—Menopausal symptoms—Esomeprazole—Barrett's esophagus	0.00413	0.0147	CcSEcCtD
Mifepristone—Menopausal symptoms—Omeprazole—Barrett's esophagus	0.00413	0.0147	CcSEcCtD
Mifepristone—Thirst—Omeprazole—Barrett's esophagus	0.00409	0.0146	CcSEcCtD
Mifepristone—Thirst—Esomeprazole—Barrett's esophagus	0.00409	0.0146	CcSEcCtD
Mifepristone—Hypoglycaemia—Esomeprazole—Barrett's esophagus	0.00399	0.0142	CcSEcCtD
Mifepristone—Hypoglycaemia—Omeprazole—Barrett's esophagus	0.00399	0.0142	CcSEcCtD
Mifepristone—Pain in extremity—Omeprazole—Barrett's esophagus	0.00389	0.0139	CcSEcCtD
Mifepristone—Pain in extremity—Esomeprazole—Barrett's esophagus	0.00389	0.0139	CcSEcCtD
Mifepristone—PGR—Nuclear Receptors—NR1I2—Barrett's esophagus	0.00374	0.0497	CbGpPWpGaD
Mifepristone—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.00354	0.0126	CcSEcCtD
Mifepristone—Hypokalaemia—Omeprazole—Barrett's esophagus	0.00354	0.0126	CcSEcCtD
Mifepristone—Breast disorder—Omeprazole—Barrett's esophagus	0.00352	0.0126	CcSEcCtD
Mifepristone—Breast disorder—Esomeprazole—Barrett's esophagus	0.00352	0.0126	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	0.00351	0.0125	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Omeprazole—Barrett's esophagus	0.00351	0.0125	CcSEcCtD
Mifepristone—Cramp muscle—Esomeprazole—Barrett's esophagus	0.00351	0.0125	CcSEcCtD
Mifepristone—Cramp muscle—Omeprazole—Barrett's esophagus	0.00351	0.0125	CcSEcCtD
Mifepristone—Muscular weakness—Esomeprazole—Barrett's esophagus	0.00343	0.0123	CcSEcCtD
Mifepristone—Muscular weakness—Omeprazole—Barrett's esophagus	0.00343	0.0123	CcSEcCtD
Mifepristone—Infestation NOS—Esomeprazole—Barrett's esophagus	0.003	0.0107	CcSEcCtD
Mifepristone—Infestation—Esomeprazole—Barrett's esophagus	0.003	0.0107	CcSEcCtD
Mifepristone—Infestation—Omeprazole—Barrett's esophagus	0.003	0.0107	CcSEcCtD
Mifepristone—Infestation NOS—Omeprazole—Barrett's esophagus	0.003	0.0107	CcSEcCtD
Mifepristone—PGR—Nuclear Receptor transcription pathway—NR1I2—Barrett's esophagus	0.00295	0.0393	CbGpPWpGaD
Mifepristone—AR—Nuclear Receptors—NR1I2—Barrett's esophagus	0.00285	0.0378	CbGpPWpGaD
Mifepristone—Sinusitis—Omeprazole—Barrett's esophagus	0.00282	0.01	CcSEcCtD
Mifepristone—Sinusitis—Esomeprazole—Barrett's esophagus	0.00282	0.01	CcSEcCtD
Mifepristone—Oedema peripheral—Omeprazole—Barrett's esophagus	0.00265	0.00947	CcSEcCtD
Mifepristone—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.00265	0.00947	CcSEcCtD
Mifepristone—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.00265	0.00945	CcSEcCtD
Mifepristone—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.00265	0.00945	CcSEcCtD
Mifepristone—ABCC1—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.00258	0.0344	CbGpPWpGaD
Mifepristone—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00243	0.00867	CcSEcCtD
Mifepristone—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00243	0.00867	CcSEcCtD
Mifepristone—Chills—Omeprazole—Barrett's esophagus	0.00242	0.00863	CcSEcCtD
Mifepristone—Chills—Esomeprazole—Barrett's esophagus	0.00242	0.00863	CcSEcCtD
Mifepristone—Mental disorder—Omeprazole—Barrett's esophagus	0.00236	0.00842	CcSEcCtD
Mifepristone—Mental disorder—Esomeprazole—Barrett's esophagus	0.00236	0.00842	CcSEcCtD
Mifepristone—Malnutrition—Omeprazole—Barrett's esophagus	0.00235	0.00837	CcSEcCtD
Mifepristone—Malnutrition—Esomeprazole—Barrett's esophagus	0.00235	0.00837	CcSEcCtD
Mifepristone—Back pain—Omeprazole—Barrett's esophagus	0.00227	0.0081	CcSEcCtD
Mifepristone—Back pain—Esomeprazole—Barrett's esophagus	0.00227	0.0081	CcSEcCtD
Mifepristone—Muscle spasms—Omeprazole—Barrett's esophagus	0.00225	0.00805	CcSEcCtD
Mifepristone—Muscle spasms—Esomeprazole—Barrett's esophagus	0.00225	0.00805	CcSEcCtD
Mifepristone—AR—Nuclear Receptor transcription pathway—NR1I2—Barrett's esophagus	0.00225	0.0299	CbGpPWpGaD
Mifepristone—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00221	0.0294	CbGpPWpGaD
Mifepristone—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.00218	0.00777	CcSEcCtD
Mifepristone—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.00218	0.00777	CcSEcCtD
Mifepristone—NR3C1—Nuclear Receptors—NR1I2—Barrett's esophagus	0.00216	0.0287	CbGpPWpGaD
Mifepristone—Angioedema—Omeprazole—Barrett's esophagus	0.00214	0.00765	CcSEcCtD
Mifepristone—Angioedema—Esomeprazole—Barrett's esophagus	0.00214	0.00765	CcSEcCtD
Mifepristone—Malaise—Esomeprazole—Barrett's esophagus	0.00211	0.00755	CcSEcCtD
Mifepristone—Malaise—Omeprazole—Barrett's esophagus	0.00211	0.00755	CcSEcCtD
Mifepristone—Hypertension—Omeprazole—Barrett's esophagus	0.00202	0.00723	CcSEcCtD
Mifepristone—Hypertension—Esomeprazole—Barrett's esophagus	0.00202	0.00723	CcSEcCtD
Mifepristone—Myalgia—Omeprazole—Barrett's esophagus	0.002	0.00713	CcSEcCtD
Mifepristone—Arthralgia—Esomeprazole—Barrett's esophagus	0.002	0.00713	CcSEcCtD
Mifepristone—Arthralgia—Omeprazole—Barrett's esophagus	0.002	0.00713	CcSEcCtD
Mifepristone—Myalgia—Esomeprazole—Barrett's esophagus	0.002	0.00713	CcSEcCtD
Mifepristone—Anxiety—Omeprazole—Barrett's esophagus	0.00199	0.0071	CcSEcCtD
Mifepristone—Anxiety—Esomeprazole—Barrett's esophagus	0.00199	0.0071	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00198	0.00708	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00198	0.00708	CcSEcCtD
Mifepristone—Discomfort—Esomeprazole—Barrett's esophagus	0.00197	0.00704	CcSEcCtD
Mifepristone—Discomfort—Omeprazole—Barrett's esophagus	0.00197	0.00704	CcSEcCtD
Mifepristone—Dry mouth—Esomeprazole—Barrett's esophagus	0.00195	0.00697	CcSEcCtD
Mifepristone—Dry mouth—Omeprazole—Barrett's esophagus	0.00195	0.00697	CcSEcCtD
Mifepristone—NR3C1—AP-1 transcription factor network—CRTC1—Barrett's esophagus	0.00191	0.0254	CbGpPWpGaD
Mifepristone—Infection—Esomeprazole—Barrett's esophagus	0.0019	0.00679	CcSEcCtD
Mifepristone—Infection—Omeprazole—Barrett's esophagus	0.0019	0.00679	CcSEcCtD
Mifepristone—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00188	0.0067	CcSEcCtD
Mifepristone—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00188	0.0067	CcSEcCtD
Mifepristone—Skin disorder—Omeprazole—Barrett's esophagus	0.00186	0.00664	CcSEcCtD
Mifepristone—Skin disorder—Esomeprazole—Barrett's esophagus	0.00186	0.00664	CcSEcCtD
Mifepristone—ABCC1—Irinotecan Pathway—APC—Barrett's esophagus	0.00185	0.0246	CbGpPWpGaD
Mifepristone—Anorexia—Omeprazole—Barrett's esophagus	0.00182	0.00651	CcSEcCtD
Mifepristone—Anorexia—Esomeprazole—Barrett's esophagus	0.00182	0.00651	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.00174	0.00622	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.00174	0.00622	CcSEcCtD
Mifepristone—Insomnia—Esomeprazole—Barrett's esophagus	0.00173	0.00618	CcSEcCtD
Mifepristone—Insomnia—Omeprazole—Barrett's esophagus	0.00173	0.00618	CcSEcCtD
Mifepristone—NR3C1—Nuclear Receptor transcription pathway—NR1I2—Barrett's esophagus	0.00171	0.0227	CbGpPWpGaD
Mifepristone—Dyspnoea—Esomeprazole—Barrett's esophagus	0.00171	0.00609	CcSEcCtD
Mifepristone—Dyspnoea—Omeprazole—Barrett's esophagus	0.00171	0.00609	CcSEcCtD
Mifepristone—Somnolence—Omeprazole—Barrett's esophagus	0.0017	0.00607	CcSEcCtD
Mifepristone—Somnolence—Esomeprazole—Barrett's esophagus	0.0017	0.00607	CcSEcCtD
Mifepristone—Decreased appetite—Esomeprazole—Barrett's esophagus	0.00166	0.00594	CcSEcCtD
Mifepristone—Decreased appetite—Omeprazole—Barrett's esophagus	0.00166	0.00594	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.00165	0.0059	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.00165	0.0059	CcSEcCtD
Mifepristone—Fatigue—Esomeprazole—Barrett's esophagus	0.00165	0.00589	CcSEcCtD
Mifepristone—Fatigue—Omeprazole—Barrett's esophagus	0.00165	0.00589	CcSEcCtD
Mifepristone—Pain—Esomeprazole—Barrett's esophagus	0.00164	0.00584	CcSEcCtD
Mifepristone—Constipation—Omeprazole—Barrett's esophagus	0.00164	0.00584	CcSEcCtD
Mifepristone—Constipation—Esomeprazole—Barrett's esophagus	0.00164	0.00584	CcSEcCtD
Mifepristone—Pain—Omeprazole—Barrett's esophagus	0.00164	0.00584	CcSEcCtD
Mifepristone—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.00158	0.00563	CcSEcCtD
Mifepristone—Feeling abnormal—Omeprazole—Barrett's esophagus	0.00158	0.00563	CcSEcCtD
Mifepristone—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.00157	0.00559	CcSEcCtD
Mifepristone—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.00157	0.00559	CcSEcCtD
Mifepristone—Urticaria—Esomeprazole—Barrett's esophagus	0.00152	0.00543	CcSEcCtD
Mifepristone—Urticaria—Omeprazole—Barrett's esophagus	0.00152	0.00543	CcSEcCtD
Mifepristone—Body temperature increased—Omeprazole—Barrett's esophagus	0.00151	0.0054	CcSEcCtD
Mifepristone—Body temperature increased—Esomeprazole—Barrett's esophagus	0.00151	0.0054	CcSEcCtD
Mifepristone—Abdominal pain—Esomeprazole—Barrett's esophagus	0.00151	0.0054	CcSEcCtD
Mifepristone—Abdominal pain—Omeprazole—Barrett's esophagus	0.00151	0.0054	CcSEcCtD
Mifepristone—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00148	0.0196	CbGpPWpGaD
Mifepristone—CYP3A7—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00146	0.0194	CbGpPWpGaD
Mifepristone—Hypersensitivity—Omeprazole—Barrett's esophagus	0.00141	0.00503	CcSEcCtD
Mifepristone—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.00141	0.00503	CcSEcCtD
Mifepristone—Asthenia—Omeprazole—Barrett's esophagus	0.00137	0.0049	CcSEcCtD
Mifepristone—Asthenia—Esomeprazole—Barrett's esophagus	0.00137	0.0049	CcSEcCtD
Mifepristone—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00136	0.0181	CbGpPWpGaD
Mifepristone—Pruritus—Esomeprazole—Barrett's esophagus	0.00135	0.00483	CcSEcCtD
Mifepristone—Pruritus—Omeprazole—Barrett's esophagus	0.00135	0.00483	CcSEcCtD
Mifepristone—Diarrhoea—Omeprazole—Barrett's esophagus	0.00131	0.00467	CcSEcCtD
Mifepristone—Diarrhoea—Esomeprazole—Barrett's esophagus	0.00131	0.00467	CcSEcCtD
Mifepristone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00127	0.0169	CbGpPWpGaD
Mifepristone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00127	0.0169	CbGpPWpGaD
Mifepristone—Dizziness—Esomeprazole—Barrett's esophagus	0.00127	0.00452	CcSEcCtD
Mifepristone—Dizziness—Omeprazole—Barrett's esophagus	0.00127	0.00452	CcSEcCtD
Mifepristone—PGR—Nuclear Receptors—PPARG—Barrett's esophagus	0.00123	0.0163	CbGpPWpGaD
Mifepristone—Vomiting—Esomeprazole—Barrett's esophagus	0.00122	0.00434	CcSEcCtD
Mifepristone—Vomiting—Omeprazole—Barrett's esophagus	0.00122	0.00434	CcSEcCtD
Mifepristone—Rash—Omeprazole—Barrett's esophagus	0.00121	0.00431	CcSEcCtD
Mifepristone—Rash—Esomeprazole—Barrett's esophagus	0.00121	0.00431	CcSEcCtD
Mifepristone—Dermatitis—Omeprazole—Barrett's esophagus	0.00121	0.0043	CcSEcCtD
Mifepristone—Dermatitis—Esomeprazole—Barrett's esophagus	0.00121	0.0043	CcSEcCtD
Mifepristone—Headache—Esomeprazole—Barrett's esophagus	0.0012	0.00428	CcSEcCtD
Mifepristone—Headache—Omeprazole—Barrett's esophagus	0.0012	0.00428	CcSEcCtD
Mifepristone—CYP3A7—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.0012	0.0159	CbGpPWpGaD
Mifepristone—CYP3A5—Irinotecan Pathway—APC—Barrett's esophagus	0.00117	0.0155	CbGpPWpGaD
Mifepristone—Nausea—Esomeprazole—Barrett's esophagus	0.00114	0.00406	CcSEcCtD
Mifepristone—Nausea—Omeprazole—Barrett's esophagus	0.00114	0.00406	CcSEcCtD
Mifepristone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—Barrett's esophagus	0.0011	0.0146	CbGpPWpGaD
Mifepristone—ABCC1—S1P1 pathway—PTGS2—Barrett's esophagus	0.0011	0.0146	CbGpPWpGaD
Mifepristone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00107	0.0142	CbGpPWpGaD
Mifepristone—CYP3A5—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00105	0.014	CbGpPWpGaD
Mifepristone—PGR—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.000971	0.0129	CbGpPWpGaD
Mifepristone—AR—Nuclear Receptors—PPARG—Barrett's esophagus	0.000936	0.0125	CbGpPWpGaD
Mifepristone—CYP3A5—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000865	0.0115	CbGpPWpGaD
Mifepristone—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.000815	0.0108	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—CYP26A1—Barrett's esophagus	0.000807	0.0107	CbGpPWpGaD
Mifepristone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000781	0.0104	CbGpPWpGaD
Mifepristone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000781	0.0104	CbGpPWpGaD
Mifepristone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000758	0.0101	CbGpPWpGaD
Mifepristone—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000749	0.00995	CbGpPWpGaD
Mifepristone—AR—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.00074	0.00984	CbGpPWpGaD
Mifepristone—NR3C1—Nuclear Receptors—PPARG—Barrett's esophagus	0.00071	0.00945	CbGpPWpGaD
Mifepristone—CYP3A7—Biological oxidations—CYP26A1—Barrett's esophagus	0.000635	0.00845	CbGpPWpGaD
Mifepristone—CYP3A7—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000627	0.00833	CbGpPWpGaD
Mifepristone—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000615	0.00818	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—BMP4—Barrett's esophagus	0.000612	0.00814	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.000593	0.00788	CbGpPWpGaD
Mifepristone—NR3C1—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.000561	0.00747	CbGpPWpGaD
Mifepristone—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000542	0.0072	CbGpPWpGaD
Mifepristone—AR—Coregulation of Androgen receptor activity—CDKN2A—Barrett's esophagus	0.00054	0.00718	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—Barrett's esophagus	0.000535	0.00711	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.00051	0.00678	CbGpPWpGaD
Mifepristone—ABCC1—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000507	0.00674	CbGpPWpGaD
Mifepristone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000496	0.0066	CbGpPWpGaD
Mifepristone—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000489	0.00651	CbGpPWpGaD
Mifepristone—NR3C1—Endoderm Differentiation—APC—Barrett's esophagus	0.000462	0.00615	CbGpPWpGaD
Mifepristone—CYP3A5—Biological oxidations—CYP26A1—Barrett's esophagus	0.000459	0.00611	CbGpPWpGaD
Mifepristone—CYP3A5—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000453	0.00602	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.00045	0.00598	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—Barrett's esophagus	0.000434	0.00578	CbGpPWpGaD
Mifepristone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000417	0.00555	CbGpPWpGaD
Mifepristone—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000402	0.00535	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—Barrett's esophagus	0.000394	0.00524	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.000388	0.00517	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—RELA—Barrett's esophagus	0.000384	0.0051	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000369	0.00491	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—CDKN2A—Barrett's esophagus	0.000367	0.00488	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—CXCL8—Barrett's esophagus	0.000333	0.00442	CbGpPWpGaD
Mifepristone—CYP2D6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000327	0.00434	CbGpPWpGaD
Mifepristone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—Barrett's esophagus	0.000325	0.00433	CbGpPWpGaD
Mifepristone—CYP2D6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000322	0.00428	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000313	0.00416	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—RELA—Barrett's esophagus	0.000311	0.00413	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.000295	0.00392	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—Barrett's esophagus	0.000293	0.0039	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000267	0.00355	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—PPARG—Barrett's esophagus	0.000266	0.00353	CbGpPWpGaD
Mifepristone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000257	0.00342	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—NR1I2—Barrett's esophagus	0.000245	0.00326	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	0.000231	0.00307	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	0.000214	0.00284	CbGpPWpGaD
Mifepristone—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000211	0.0028	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—TP53—Barrett's esophagus	0.000204	0.00271	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000202	0.00269	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000192	0.00255	CbGpPWpGaD
Mifepristone—AR—Gene Expression—NR1I2—Barrett's esophagus	0.000187	0.00249	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—TP53—Barrett's esophagus	0.00018	0.00239	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	0.000175	0.00233	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—PPARG—Barrett's esophagus	0.000168	0.00223	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTGES—Barrett's esophagus	0.000164	0.00219	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	0.000162	0.00216	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—GAST—Barrett's esophagus	0.00015	0.002	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000149	0.00198	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	0.000145	0.00193	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTGES—Barrett's esophagus	0.000143	0.00191	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—NR1I2—Barrett's esophagus	0.000142	0.00189	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—PPARG—Barrett's esophagus	0.000128	0.0017	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CYP26A1—Barrett's esophagus	0.000125	0.00166	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	0.00012	0.0016	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000109	0.00145	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CYP26A1—Barrett's esophagus	0.000109	0.00145	CbGpPWpGaD
Mifepristone—ABCC1—Disease—SLC9A1—Barrett's esophagus	0.000107	0.00143	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTGES—Barrett's esophagus	0.000104	0.00138	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SST—Barrett's esophagus	0.000103	0.00137	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—PPARG—Barrett's esophagus	9.7e-05	0.00129	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	9.21e-05	0.00122	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	9.12e-05	0.00121	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—SLC9A1—Barrett's esophagus	8.98e-05	0.00119	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	8.25e-05	0.0011	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—PPARG—Barrett's esophagus	8.08e-05	0.00107	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP26A1—Barrett's esophagus	7.86e-05	0.00104	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—SLC9A1—Barrett's esophagus	7.83e-05	0.00104	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTGES—Barrett's esophagus	7.82e-05	0.00104	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTGES—Barrett's esophagus	7.37e-05	0.00098	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	7.24e-05	0.000963	CbGpPWpGaD
Mifepristone—AR—Gene Expression—PPARG—Barrett's esophagus	6.15e-05	0.000818	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	5.93e-05	0.000788	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—SLC9A1—Barrett's esophagus	5.66e-05	0.000753	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	5.59e-05	0.000743	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—APC—Barrett's esophagus	5.44e-05	0.000724	CbGpPWpGaD
Mifepristone—ABCC1—Disease—APC—Barrett's esophagus	5.07e-05	0.000675	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	4.91e-05	0.000653	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTGES—Barrett's esophagus	4.82e-05	0.000641	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—PPARG—Barrett's esophagus	4.67e-05	0.000621	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	4.27e-05	0.000568	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—RELA—Barrett's esophagus	4.25e-05	0.000565	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PPARG—Barrett's esophagus	4.1e-05	0.000545	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	4.03e-05	0.000535	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CXCL8—Barrett's esophagus	4.01e-05	0.000533	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTGS2—Barrett's esophagus	3.85e-05	0.000512	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	3.65e-05	0.000486	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PPARG—Barrett's esophagus	3.58e-05	0.000476	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTGS2—Barrett's esophagus	3.23e-05	0.000429	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTGS2—Barrett's esophagus	2.81e-05	0.000374	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	2.63e-05	0.00035	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PPARG—Barrett's esophagus	2.58e-05	0.000344	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TP53—Barrett's esophagus	2.46e-05	0.000327	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTGS2—Barrett's esophagus	2.03e-05	0.00027	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PPARG—Barrett's esophagus	1.95e-05	0.000259	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PPARG—Barrett's esophagus	1.84e-05	0.000244	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTGS2—Barrett's esophagus	1.53e-05	0.000204	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	1.45e-05	0.000192	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PPARG—Barrett's esophagus	1.2e-05	0.00016	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	9.45e-06	0.000126	CbGpPWpGaD
